Havells India shares among top losers on Nifty Next 50 yesterday, fall 1.3% Moneycontrol analysis indicates a bullish sentiment for Havells India as of July 22, 2025.

After prematurely ending two phase 3 depression trials last year, Relmada Therapeutics has formally given up on the asset they were testing. The Florida-based biotech terminated its license ...

Reliance Retail's Q1FY26 net profit surged 28.3% YoY to ₹3,271 crore, despite being less than the ₹3,545 crore reported in the previous quarter.

Prediction: These 3 Market-Leading Artificial Intelligence (AI) Stocks Will Eventually Plunge 50% (or More) By Sean Williams – Jul 22, 2025 at 3:51AM ...

Cary Audio's new DMS-300A is a powerful two-channel amp with Hi-Res Audio streaming built in ...

Director Jeetu Joseph opened up recently about Drishyam 3, which will star Ajay Devgn in Hindi and Mohanlal in the Malayalam versions.  ...

Havells India shares rose nearly 3 per cent. However, brokerages lowered target prices, citing weak Lloyd and ECD segments. The company registered a 14.7 per cent YoY decline in consolidated net ...

The Enforcement Directorate is raiding premises linked to Reliance Group chairman Anil Ambani in Delhi and Mumbai in connection with a money laundering case, sources said.

Roche gambled on an all-comer design for trials of its COPD candidate astegolimab, a move that may prove costly as it fails a phase 3 test.

McIntosh's new CR106 pre-amp and audio matrix is designed for high-end multiroom hi-fi, and delivers six fully customisable zones. You can team multiple units to create a 30-zone setup.

Havells India Ltd. expects to see steady growth across all business categories, with a focus on capacity expansion, Chairman and Managing Director Anil Rai Gupta said.

50 attacks in 24 hours: Operation BAAM marks new phase in Baloch insurgency, Pak Army struggles to respond The BLA specifically claimed responsibility for killing at least 18 Pakistani soldiers in ...